應該沒有。2013年一月才完成臨床一期

從他們公司網站上抄來的：
In 2012, Alnylam and Ascletis Pharmaceuticals (Hangzhou) Co., Ltd., a privately held U.S.-China joint venture pharmaceutical company, formed a strategic collaboration for the development of ALN-VSP in China. Alnylam will retain all rights in the rest of the world, and is eligible to receive milestones and royalties from Ascletis based on product sales.
中國有杭州的公司和他們合作，你可以讓親戚去問問是否有中國臨床。